Anaptysbio, Inc. · NASDAQ:ANAB
Morgan Stanley reported a 6.30% stake in Anaptysbio, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 5, 2025
Morgan Stanley reported a 6.30% stake in Anaptysbio, Inc., 1,845,002 shares, as a passive investor on Jun 30, 2025. Filed Aug 5, 2025 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 1,845,002
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.30% | 1,845,002 |
| Morgan Stanley Capital Services LLC | 5.20% | 1,525,502 |
Source
Related
- Anaptysbio, Inc.
- Morgan Stanley
- Anaptysbio, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Feb 11, 2026
- Form 4 · Renton Hollings · Oct 2, 2026
- Form 4 · Orwin John A · Sep 17, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Schmid John P. · Jun 17, 2026
- Form 4 · Renton Hollings · Jun 17, 2026